Skip to content

Clinical trials

Phase 2 Macular Edema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Edema Phase: Phase 2 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20072
20083
20092
20101
20113
20123
20131
20143
20152
20193
20211
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated5
Withdrawn2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
Clearside Biomedical, Inc.2
Novartis Pharmaceuticals2
Unity Biotechnology, Inc.2
Aerie Pharmaceuticals1
Alimera Sciences1
Arman Mashayekhi1
Boehringer Ingelheim1
California Retina Consultants1
CoMentis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Edema31
Diabetes Mellitus7
Diabetic Retinopathy7
Retinal Vein Occlusion7
Retinal Diseases5
Uveitis5
Macular Degeneration4
Uveitis, Posterior3
Edema2
Eye Diseases2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.